Global Recombinant Human Erythropoietin (rhEPO) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Published On: April 2019 | Report ID: 149805 | Category: Medical DevicesPages: 115

The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.

Scope of the Report:

The worldwide market for Recombinant Human Erythropoietin (rhEPO) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Recombinant Human Erythropoietin (rhEPO) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

3SBio

Shanghai Chemo

Chengdu Diao

NCPC Genetech

Kyowa Hakko Kirin

Shandong Kexing

Ahua Pharmaceutical

Biosidus

Dragon Pharma

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

ESRD

Cancer

HIV

Wounds and neural disease

Market Segment by Applications, can be divided into

Hospitals

Retail Pharmacies

There are 15 Chapters to deeply display the global Recombinant Human Erythropoietin (rhEPO) market.

Chapter 1, to describe Recombinant Human Erythropoietin (rhEPO) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Recombinant Human Erythropoietin (rhEPO), with sales, revenue, and price of Recombinant Human Erythropoietin (rhEPO), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Recombinant Human Erythropoietin (rhEPO), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Recombinant Human Erythropoietin (rhEPO) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Recombinant Human Erythropoietin (rhEPO) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Recombinant Human Erythropoietin (rhEPO) Introduction

1.2 Market Analysis by Type

1.2.1 ESRD

1.2.2 Cancer

1.2.3 HIV

1.2.4 Wounds and neural disease

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Retail Pharmacies

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 3SBio

2.1.1 Business Overview

2.1.2 Recombinant Human Erythropoietin (rhEPO) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 3SBio Recombinant Human Erythropoietin (rhEPO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Shanghai Chemo

2.2.1 Business Overview

2.2.2 Recombinant Human Erythropoietin (rhEPO) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Chengdu Diao

2.3.1 Business Overview

2.3.2 Recombinant Human Erythropoietin (rhEPO) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 NCPC Genetech

2.4.1 Business Overview

2.4.2 Recombinant Human Erythropoietin (rhEPO) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Kyowa Hakko Kirin

2.5.1 Business Overview

2.5.2 Recombinant Human Erythropoietin (rhEPO) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Shandong Kexing

2.6.1 Business Overview

2.6.2 Recombinant Human Erythropoietin (rhEPO) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Ahua Pharmaceutical

2.7.1 Business Overview

2.7.2 Recombinant Human Erythropoietin (rhEPO) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Biosidus

2.8.1 Business Overview

2.8.2 Recombinant Human Erythropoietin (rhEPO) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Biosidus Recombinant Human Erythropoietin (rhEPO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Dragon Pharma

2.9.1 Business Overview

2.9.2 Recombinant Human Erythropoietin (rhEPO) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Recombinant Human Erythropoietin (rhEPO) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Recombinant Human Erythropoietin (rhEPO) Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Recombinant Human Erythropoietin (rhEPO) Manufacturer Market Share in 2017

3.3.2 Top 6 Recombinant Human Erythropoietin (rhEPO) Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Recombinant Human Erythropoietin (rhEPO) Market Analysis by Regions

4.1 Global Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Market Share by Regions

4.1.1 Global Recombinant Human Erythropoietin (rhEPO) Sales and Market Share by Regions (2013-2018)

4.1.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue and Market Share by Regions (2013-2018)

4.2 North America Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

4.3 Europe Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

4.5 South America Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

5 North America Recombinant Human Erythropoietin (rhEPO) by Countries

5.1 North America Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Market Share by Countries

5.1.1 North America Recombinant Human Erythropoietin (rhEPO) Sales and Market Share by Countries (2013-2018)

5.1.2 North America Recombinant Human Erythropoietin (rhEPO) Revenue and Market Share by Countries (2013-2018)

5.2 United States Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

5.3 Canada Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

5.4 Mexico Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

6 Europe Recombinant Human Erythropoietin (rhEPO) by Countries

6.1 Europe Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Market Share by Countries

6.1.1 Europe Recombinant Human Erythropoietin (rhEPO) Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Recombinant Human Erythropoietin (rhEPO) Revenue and Market Share by Countries (2013-2018)

6.2 Germany Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

6.3 UK Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

6.4 France Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

6.5 Russia Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

6.6 Italy Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

7 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) by Countries

7.1 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Revenue and Market Share by Countries (2013-2018)

7.2 China Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

7.3 Japan Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

7.4 Korea Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

7.5 India Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

8 South America Recombinant Human Erythropoietin (rhEPO) by Countries

8.1 South America Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Market Share by Countries

8.1.1 South America Recombinant Human Erythropoietin (rhEPO) Sales and Market Share by Countries (2013-2018)

8.1.2 South America Recombinant Human Erythropoietin (rhEPO) Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

8.3 Argentina Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

8.4 Colombia Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

9 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) by Countries

9.1 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

9.3 UAE Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

9.4 Egypt Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

9.5 Nigeria Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

9.6 South Africa Recombinant Human Erythropoietin (rhEPO) Sales and Growth Rate (2013-2018)

10 Global Recombinant Human Erythropoietin (rhEPO) Market Segment by Type

10.1 Global Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Recombinant Human Erythropoietin (rhEPO) Sales and Market Share by Type (2013-2018)

10.1.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue and Market Share by Type (2013-2018)

10.2 ESRD Sales Growth and Price

10.2.1 Global ESRD Sales Growth (2013-2018)

10.2.2 Global ESRD Price (2013-2018)

10.3 Cancer Sales Growth and Price

10.3.1 Global Cancer Sales Growth (2013-2018)

10.3.2 Global Cancer Price (2013-2018)

10.4 HIV Sales Growth and Price

10.4.1 Global HIV Sales Growth (2013-2018)

10.4.2 Global HIV Price (2013-2018)

10.5 Wounds and neural disease Sales Growth and Price

10.5.1 Global Wounds and neural disease Sales Growth (2013-2018)

10.5.2 Global Wounds and neural disease Price (2013-2018)

11 Global Recombinant Human Erythropoietin (rhEPO) Market Segment by Application

11.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Retail Pharmacies Sales Growth (2013-2018)

12 Recombinant Human Erythropoietin (rhEPO) Market Forecast (2018-2023)

12.1 Global Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Growth Rate (2018-2023)

12.2 Recombinant Human Erythropoietin (rhEPO) Market Forecast by Regions (2018-2023)

12.2.1 North America Recombinant Human Erythropoietin (rhEPO) Market Forecast (2018-2023)

12.2.2 Europe Recombinant Human Erythropoietin (rhEPO) Market Forecast (2018-2023)

12.2.3 Asia-Pacific Recombinant Human Erythropoietin (rhEPO) Market Forecast (2018-2023)

12.2.4 South America Recombinant Human Erythropoietin (rhEPO) Market Forecast (2018-2023)

12.2.5 Middle East and Africa Recombinant Human Erythropoietin (rhEPO) Market Forecast (2018-2023)

12.3 Recombinant Human Erythropoietin (rhEPO) Market Forecast by Type (2018-2023)

12.3.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Forecast by Type (2018-2023)

12.3.2 Global Recombinant Human Erythropoietin (rhEPO) Market Share Forecast by Type (2018-2023)

12.4 Recombinant Human Erythropoietin (rhEPO) Market Forecast by Application (2018-2023)

12.4.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Forecast by Application (2018-2023)

12.4.2 Global Recombinant Human Erythropoietin (rhEPO) Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@mrinsights.biz

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.